DK2561876T3 - Formuleringer af deoxycholsyre og salte deraf - Google Patents

Formuleringer af deoxycholsyre og salte deraf

Info

Publication number
DK2561876T3
DK2561876T3 DK11178538.2T DK11178538T DK2561876T3 DK 2561876 T3 DK2561876 T3 DK 2561876T3 DK 11178538 T DK11178538 T DK 11178538T DK 2561876 T3 DK2561876 T3 DK 2561876T3
Authority
DK
Denmark
Prior art keywords
formulations
salts
deoxycholic acid
deoxycholic
acid
Prior art date
Application number
DK11178538.2T
Other languages
English (en)
Inventor
Robert Emil Hodge
Jeffrey Douglas Webster
Robert M Moriarty
Original Assignee
Kythera Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kythera Biopharmaceuticals Inc filed Critical Kythera Biopharmaceuticals Inc
Application granted granted Critical
Publication of DK2561876T3 publication Critical patent/DK2561876T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK11178538.2T 2011-08-23 2011-08-23 Formuleringer af deoxycholsyre og salte deraf DK2561876T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11178538.2A EP2561876B1 (en) 2011-08-23 2011-08-23 Formulations of Deoxycholic Acid and Salts Thereof

Publications (1)

Publication Number Publication Date
DK2561876T3 true DK2561876T3 (da) 2014-07-21

Family

ID=44651163

Family Applications (2)

Application Number Title Priority Date Filing Date
DK17188946.2T DK3305298T3 (da) 2011-08-23 2011-08-23 Formuleringer af deoxycholsyre og salte deraf
DK11178538.2T DK2561876T3 (da) 2011-08-23 2011-08-23 Formuleringer af deoxycholsyre og salte deraf

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK17188946.2T DK3305298T3 (da) 2011-08-23 2011-08-23 Formuleringer af deoxycholsyre og salte deraf

Country Status (11)

Country Link
EP (4) EP2735310B1 (da)
CY (1) CY1115372T1 (da)
DK (2) DK3305298T3 (da)
ES (3) ES2738500T3 (da)
HR (1) HRP20140676T1 (da)
HU (1) HUE046047T2 (da)
PL (2) PL3305298T3 (da)
PT (2) PT3305298T (da)
RS (1) RS53419B (da)
SI (1) SI2561876T1 (da)
SM (1) SMT201400094B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
MX363465B (es) 2011-02-18 2019-03-25 Kythera Biopharmaceuticals Inc Tratamiento de la grasa submental.
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
JP2018532806A (ja) * 2015-11-04 2018-11-08 キセラ バイオファーマシューティカルズ インコーポレイテッド デオキシコール酸およびその塩による蓄積脂肪の処置方法
CN118005707A (zh) * 2024-01-18 2024-05-10 山东省食品药品检验研究院 一种脱氧胆酸钠晶型a及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754709B1 (fr) 1996-10-23 1999-03-05 Sanofi Sa Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
US6417179B1 (en) * 1998-10-13 2002-07-09 Craig G. Burkhart Ear wax solution
US20050048126A1 (en) * 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
MXPA06013437A (es) 2004-05-19 2007-03-23 Los Angeles Biomed Res Inst Uso de un detergente para la eliminacion no quirurgica de grasa.
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US7754230B2 (en) 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20090317376A1 (en) 2005-06-06 2009-12-24 Georgetown University Medical School Compositions And Methods For Lipo Modeling
TW201011755A (en) 2008-09-10 2010-03-16 Skymedi Corp Flash memory system and its data recovery method

Also Published As

Publication number Publication date
SMT201400094B (it) 2014-11-10
EP3305298B1 (en) 2019-05-01
EP2735310B1 (en) 2017-10-11
EP2561876A1 (en) 2013-02-27
DK3305298T3 (da) 2019-07-29
ES2655465T3 (es) 2018-02-20
SI2561876T1 (sl) 2014-08-29
EP3511007A1 (en) 2019-07-17
EP2735310A1 (en) 2014-05-28
EP2561876B1 (en) 2014-04-16
CY1115372T1 (el) 2017-01-04
RS53419B (sr) 2014-12-31
PL2561876T3 (pl) 2014-09-30
ES2738500T3 (es) 2020-01-23
PT3305298T (pt) 2019-07-29
PT2561876E (pt) 2014-07-18
ES2478447T3 (es) 2014-07-22
HRP20140676T1 (hr) 2014-10-10
HUE046047T2 (hu) 2020-01-28
PL3305298T3 (pl) 2020-02-28
EP3305298A1 (en) 2018-04-11

Similar Documents

Publication Publication Date Title
DK2892912T3 (da) C17-alkandiyl og alkenediylderivater af oleanolsyre og fremgangsmåder til anvendelse deraf
DK3235812T3 (da) Deutererede derivater af ivacaftor
DK3336097T3 (da) Fremstilling af ikke-krystallinsk obeticholsyre
IL249056B (en) Phenothiazine diaminium salts and their use
DK3725778T4 (da) Formuleringer af enzalutamid
DK3050972T3 (da) Fremgangsmåder til fremstilling af eicosapentaensyre i thraustochytrider
DK2528602T4 (da) Formuleringer af bendamustin
DK2931891T3 (da) Rna-styret modificering af menneskelige genomer
EP2852326A4 (en) INSPECTION ON SITE TO POSITION IMPLANTS
EP2739316A4 (en) RADIOMARQUATED INHIBITORS OF MEMBRANE ANTIGEN SPECIFIC TO THE PROSTATE
DK2688557T3 (da) Fremgangsmåder og sammensætninger til behandling af forstyrelse af opmærksomhed
DK2562155T3 (da) Hydroxaminsyrederivat
HUE038759T2 (hu) Terápiás nukleázkészítmények és eljárások
DK2909182T3 (da) Fremstilling af og formulering omfattende en mek-inhibitor
DK2917358T3 (da) Sammensætninger og fremgangsmåder til biologisk fremstilling af fedtsyrederivater
SMT201600272B (it) Diidropiridinoni e piperidinoni arilici come inibitori di mgat2
DK2451771T3 (da) Salte af rasagilin og farmaceutiske fremstillingsmåder heraf
ZA201401027B (en) Formulations of deoxycholic acid and salts thereof
DK3831406T3 (da) Stabile formuleringer af Neisseria-Meningitidis-RLP2086-antigener
DK2931313T3 (da) Opløsningsformuleringer af manipulerede anti-il-23p19-antistoffer
DK2646452T3 (da) Chlorering af carbohydrater og carbohydratderivater
DK2427417T3 (da) Salte af 3-pentylphenyleddikesyre og farmaceutiske anvendelser deraf
HRP20180567T1 (hr) Farmaceutski pripravak omeprazola
DK2673363T3 (da) Behandling af angiogenesesygdomme
DK2858989T3 (da) Amorf form af en AKT-hæmmende pyrimidinyl-cyclopentan-forbindelse, sammensætninger deraf og fremgangsmåder dertil